About 400 reports

  • TUBERCULOSIS VACCINE
  • APAC Tuberculosis Vaccines Market

Executive Summary Surging old age population, rising polluted drinking water, development of bioterrorism combined with rising technological development in vaccine industry, growing awareness towards individual health along with initiative taken by various government and non-government institutions have been driving the demand...

  • Vaccine
  • World
  • Market Size
  • Merck & Co., Inc.
  • Sanofi S.A.

WE HAVE A DRUG CALLED MEDACULINE, WHICH WAS FOR TUBERCULOSIS.

  • Vaccine
  • World
  • Market Size
  • AbbVie Inc.
  • Sanofi S.A.
  • Market drivers

Bovine tuberculosis - Bovine tuberculosis is a chronic disorder of cattle caused by Mycobacterium bovis, which is a Gram-positive, acid-fast bacterium.

  • Vaccine
  • Boehringer Ingelheim GmbH
  • Elanco
  • Merck & Co., Inc.
  • Merial Limited
  • Tuberculosis and BCG Vaccine in China
  • Bacillus Calmette-Guerin (BCG) Vaccine

This study focuses on China’s Metal Finishing Chemicals industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of...

  • Vaccine
  • China
  • Demand
  • Market Size
  • Supply

WE HAVE A DRUG CALLED MEDACULINE, WHICH WAS FOR TUBERCULOSIS.

  • Vaccine
  • World
  • Market Size
  • AbbVie Inc.
  • Pfizer Inc.
  • Vaccine Adjuvant Market: Revenue in USD million, by Mechanism of Action, India, 2018-2023
  • 3.4 MARKET CHALLENGES

It also contains ## mg/ ml of heat-killed Mycobacterium tuberculosis bacteria.

  • Vaccine
  • United States
  • Boehringer Ingelheim Vetmedica, Inc.
  • Brenntag AG
  • Novavax, Inc.
  • MERCK

You can easily book an appointment with one online.

  • Infectious Disease
  • Vaccine
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Global Vaccines Sterile Injectables Market

Top ## players hold majority of stake in the market ##.

  • Cardiovascular Disease
  • Diabetes
  • Endocrine Disease
  • Pathology
  • Vaccine
  • SANOFI VACCINE PRODUCT PIPELINE
  • 10.9 TRAVEL AND MISCELLANEOUS - VACCINES MARKET AND FORECAST

Global Vaccines Market to reach US$ 60 Billion by the year 2022. Pediatric vaccines market is having a dominant market share compared to Adult vaccines market. By 2022 Pediatric vaccines market share will be double the size of adult vaccines market share. Worldwide the number of infants immunized by influenza vaccines remain considerably low...

  • Vaccine
  • World
  • Forecast
  • Meningococcal group
  • Pfizer Inc.
  • Phase I
  • Status

About Human Vaccine According to the Centers for Disease Control and Prevention (CDC), a vaccine is a product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administered by mouth...

  • Vaccine
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • 4.9 TRAVEL AND MISCELLANEOUS - ADULT VACCINE ANALYSIS AND FORECAST
  • 5.2 SANOFI PASTEUR

Other Companies ##.

  • Vaccine
  • Demand
  • Forecast
  • Market Size
  • bioCSL Inc.
  • Four: Adult Preventive Vaccines 142
  • VACCINE-PREVENTABLE DISEASES, MARCH 2016

The global market for human vaccines experienced strong growth through 2015. Through 2022, growth will be fueled by continued new product introductions, indication expansions for some products and rising usage, particularly in South America, Europe, India and China. Vaccines: The World Market examines the market for vaccines used in humans...

  • Vaccine
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • TUBERCULOSIS VACCINE
  • TUBERCULOSIS VACCINE - DRUG PROFILE

Tuberculosis - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis - Pipeline Review, H2 2017, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape. Tuberculosis, commonly known as TB,...

  • Pathology
  • Tuberculosis
  • Vaccine
  • World
  • TB Drug Development, Inc.

PFIZER PIPELINE AS OF AUGUST ##, 2017.

  • Vaccine
  • Greece
  • Southern Europe
  • Novartis AG
  • Sanofi S.A.
  • 14.2 MERCK VACCINE PRODUCT PIPELINE
  • THERMOSTABLE VACCINES. IT IS ALSO COLLABORATING ON VACCINE TECHNOLOGY DEVELOPMENT FOR

Get 10% Free Customization in this Report Adult Vaccines Market is expected to be close to US$ 20 Billion by the year 2022. Because of vaccines, some diseases (like Polio and Diphtheria) are becoming rare. Vaccination can prevent certain deadly diseases in all age groups. Almost all countries around the world have introduced...

  • Vaccine
  • World
  • GlaxoSmithKline plc
  • Meningococcal group
  • Pfizer Inc.
  • 14.2 MERCK VACCINE PRODUCT PIPELINE
  • THERMOSTABLE VACCINES. IT IS ALSO COLLABORATING ON VACCINE TECHNOLOGY DEVELOPMENT FOR

Get 10% Free Customization in this Report Global Pediatric Vaccines Market is expected to cross US$ 40 Billion by the year 2022. Our analysis found that the combination and pneumococcal vaccines was the two leading vaccines segment in 2017 and they continue to dominate the market in future years as well. The market of Combos...

  • Vaccine
  • World
  • Forecast
  • Meningococcal group
  • Pfizer Inc.
  • JOHNSON & JOHNSON

AstraZeneca has one business segment: biopharmaceuticals.

  • Vaccine
  • North America
  • AstraZeneca PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • BCG

Bacille Calmette-Guerin (BCG) is a bacterium used in tuberculosis vaccines.

  • Vaccine
  • China
  • Demand
  • Market Size
  • Trade
  • JOHNSON & JOHNSON

AstraZeneca has one business segment: biopharmaceuticals.

  • Vaccine
  • United States
  • AstraZeneca PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Cattle Health Market: Revenue in USD million, by Product Type, Vaccine, Global, 2015-2023
  • BY PRODUCT TYPE

Germany is one of the largest exporters of meat in the European Union.

  • Vaccine
  • United States
  • World
  • Merck & Co., Inc.
  • Zoetis Inc.
  • GLAXOSMITHKLINE (GSK) - FORECAST FOR PEDIATRIC VACCINES SALES (MILLION US$), 2016 - 2021
  • 5.2.1 SANOFI PASTEUR - PEDIATRIC VACCINES SALES AND FORECAST (2010 - 2021)

Tdap ##.

  • Vaccine
  • Demand
  • Market Size
  • bioCSL Inc.
  • GlaxoSmithKline plc
  • CHAPTER IV VACCINES OUTPUTS AND FORECASTS
  • CHAPTER IV VACCINES OUTPUTS AND FORECASTS

THEN, ON ACCOUNT OF THE LARGE AMOUNT OF THE POPULATION, TUBERCULOSIS IS STILL ONE OF MAIN DISEASES IN CHINA.

  • Vaccine
  • China
  • Market Size
  • Supply
  • Shenzhen Kangtai Biological Products Co.
  • 5.1 VACCINES
  • 5. MARKET SEGMENTATION, BY TYPE

Germany is one of the largest exporters of meat in the European Union.

  • Vaccine
  • Abaxis, Inc.
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Elanco
  • 7.2 FARM ANIMAL HEALTHCARE

Europe is one of the largest markets for this sector in 2016.

  • Anti-Infective
  • Vaccine
  • Veterinary Healthcare
  • Europe
  • Elanco
  • 7.1.7.1.7 CHOLERA VACCINE

The global biopharmaceuticals market is estimated to reach USD 341.16 billion in 2023. The market is expected to register a CAGR of 8.5% during the forecast period (2018 – 2023). North America dominates the market due to rapid technological advancements. Increasing Acceptance for Biopharmaceuticals and Significant Market Demand Opportunities...

  • Biopharmaceutical
  • Biotechnology
  • Vaccine
  • World
  • Market Size

You can easily book an appointment with one online.

  • Vaccine
  • Becton Property Group
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Roche Group

Key strategic moves and developments List of Tables TABLE ##.

  • Therapy
  • Vaccine
  • World
  • Market Size

In the bio-products got approval, domestic ones share ##% and the ones abroad ##%.

  • Vaccine
  • China
  • Demand
  • Supply
  • Shenzhen Keing Biotech Co., Ltd
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Antimalarials
  • Clinical Trial
  • Infectious Disease
  • Malaria
  • Vaccine

The condition is worse in poor countries where the legal and regulatory oversights are the weakest, and counterfeit medicines are available to treat certain life-threatening conditions such as malaria, tuberculosis and HIV/ AIDS.

  • Vaccine
  • North America
  • United States
  • Allergan plc
  • Merck & Co., Inc.